- Veterinary Analgesics Veterinary NSAIDs, which are critical for managing pain and inflammation in animals, have become essential components of modern veterinary care for both companion and livestock animals due to their effectiveness, ease of administration, and wide applicability in post-operative, chronic, and musculoskeletal conditions
- The growing demand for veterinary NSAIDs is primarily driven by rising pet ownership, increased awareness of animal health and welfare, and a global push toward responsible pain management protocols in veterinary practice
- North America dominated the veterinary analgesics/anti-inflammatory (NSAIDS) market with the largest revenue share of 40.5% in 2024, supported by advanced veterinary infrastructure, higher pet healthcare spending, and the presence of leading pharmaceutical companies
- Asia-Pacific is expected to be the fastest-growing region in the veterinary analgesics/anti-inflammatory (NSAIDS) market during the forecast period due to growing livestock production, expanding veterinary services, and increasing disposable incomes in countries such as China and India
- Oral administration segment dominated the veterinary analgesics/anti-inflammatory (NSAIDS) market with a market share of 43.5% in 2024, driven by its convenience, better compliance among pet owners, and a broad availability of palatable formulations designed specifically for companion animals
